152 related articles for article (PubMed ID: 6943371)
1. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
2. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
3. Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.
Introna M; Allavena P; Biondi A; Colombo N; Villa A; Mantovani A
J Natl Cancer Inst; 1983 Jan; 70(1):21-6. PubMed ID: 6337291
[TBL] [Abstract][Full Text] [Related]
4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of natural killer activity by human bronchoalveolar macrophages.
Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
[TBL] [Abstract][Full Text] [Related]
6. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
8. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
9. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
10. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
[TBL] [Abstract][Full Text] [Related]
11. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
13. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
14. Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines.
de Landazuri MO; López-Botet M; Timonen T; Ortaldo JR; Herberman RB
J Immunol; 1981 Oct; 127(4):1380-3. PubMed ID: 6168686
[TBL] [Abstract][Full Text] [Related]
15. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor cells in spleens of mice with low natural killer activity.
Blair PB; Staskawicz MO; Sam JS
J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
[TBL] [Abstract][Full Text] [Related]
17. In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. II. Characterization of two different effector activities and of suppressor cells.
Treves AJ; Heidelberger E; Feldman M; Kaplan HS
J Immunol; 1978 Jul; 121(1):86-90. PubMed ID: 670709
[TBL] [Abstract][Full Text] [Related]
18. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
19. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
20. Identification and separation by bacterial adherence of human lymphocytes that suppress natural cytotoxicity.
DeBoer KP; Kleinman R; Teodorescu M
J Immunol; 1981 Jan; 126(1):276-81. PubMed ID: 6969743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
